PRMT5 and Miyoshi myopathy: Moreover, by analyzing the clinical data from 787 patients with MM from the MMRF CoMMpass database, we found that high PRMT5 expression was associated with poor progression-free survival (P = 0.015, HR = 1.472, Fig. 1C).